Vithas Hospital Nosa Senora De Fatima

At Vithas Hospital Nosa Senora De Fatima in Vigo, much of the research focuses on skin and connective tissue diseases, especially atopic dermatitis, dermatitis, and severe primary hand hyperhidrosis. These studies are designed to evaluate new treatments, assess long-term safety, and better understand how well therapies control symptoms in people living with chronic skin conditions.

• Testing novel therapies for atopic dermatitis and related inflammatory skin disease
• Evaluating the safety and effectiveness of long-term treatment approaches
• Studying new topical options for severe hand hyperhidrosis

The site’s dermatology research aims to improve day-to-day symptom control and provide safer, more durable treatment options for patients with persistent skin disorders.

This research site also contributes to studies in immune system diseases, with a strong emphasis on moderate-to-severe atopic dermatitis. The trials are mainly focused on testing targeted therapies, comparing them with placebo or treatment withdrawal, and understanding how well patients maintain their response over time.

• Assessing the efficacy of amlitelimab in atopic dermatitis
• Reviewing long-term safety in participants with chronic inflammatory disease
• Comparing active treatment with placebo or withdrawal strategies

These studies reflect an ongoing effort to improve immune-based treatment options for people whose skin disease is driven by persistent inflammation.

Research at the hospital also includes nervous system diseases, particularly disorders of consciousness and severe brain injury. The clinical work in this area is aimed at clarifying whether a treatment can help restore responsiveness and support recovery in patients with serious neurological impairment.

• Studying treatment response in disorders of consciousness
• Exploring a therapy for patients with severe brain injury
• Evaluating whether clinical improvement can be achieved in difficult-to-treat neurological conditions

Although smaller in volume than the dermatology portfolio, this line of research broadens the site’s clinical activity beyond skin disease and into challenging neurological care.